Virtual Reality Education Tool for Adolescent and Young Adult Cancer Patients

This study is testing "Life at 100.4," an immersive social virtual reality (VR) education tool. This tool aims to help adolescent and young adult cancer patients (ages 13-39) and their caregivers understand and manage febrile neutropenia, a common and serious complication of cancer treatment (fever and low white blood cells). The study will involve about 45 participants and will look at how easy the VR tool is to use and how well people accept it. You may be able to join if you are newly diagnosed with cancer or a bone marrow condition, plan to receive chemotherapy, and will have a central line. This study is currently in an unclear recruitment status.

Study design
This is an interventional study with an anticipated enrollment of 45 participants. It is designed to test the feasibility and acceptability of the VR education tool.
What's involved
You would participate in the "Life at 100.4" immersive social virtual reality education tool for up to 2 hours.
Compensation
Not stated in the trial record.
Follow-up
Your experience with the VR tool will be measured immediately after the intervention, up to 2 hours.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07224204

Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers

Recruiting
NAAges 13–39InterventionalSupportive care
Yale University
~45 participants
Updated 2026-02-25 on ClinicalTrials.gov
What's tested:Life at 100.4

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Multimodal Presence Scale for Virtual Environments
Measured over immediately post-intervention, up to 2 hours
+2 more outcomes measured
Cancer
Adolescent Cancer
Young Adult Cancer
1 sites across 1 states
Connecticut1
  • Asher Marks, MD · PRINCIPAL_INVESTIGATOR · Yale University

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Newly diagnosed with a malignancy or bone marrow failure condition
Planned to receive chemotherapy and receive a central line

Exclusion

Medical contraindication to virtual reality including head wounds and history of seizure with flashing lights
No plan to receive chemotherapy
  • Multimodal Presence Scale for Virtual Environmentsimmediately post-intervention, up to 2 hours

    A 15-item validated tool to assess presence in VR. There are five items for each of the three dimensions, Physical Presence, Social Presence, and Self-Presence, scored on a 5-point Likert scale, from 1 (strongly disagree) to 5 (strongly agree). Total score for each dimension 1-5 with higher scores indicating a stronger sense of presence in that dimension.

  • System Usability Scale (SUS)immediately post-intervention, up to 2 hours

    A 10-item questionnaire with responses provided on a Likert scale. The SUS has been applied in evaluating the usability of different websites, software, and human computer interfaces. The final score is on a scale of 0-100. Higher scores indicate more usability.

  • Technology Acceptance Model (TAC)immediately post-intervention, up to 2 hours

    Technology Acceptance Model questionnaire with questions related to Perceived Usefulness and Perceived Ease of Use. Total score range 1-5 with higher scores indicating higher acceptance and use.